Ohtake S, Nakamura S
Rinsho Ketsueki. 1989 Aug;30(8):1193-6.
At Kanazawa University 28 patients with Hodgkin's disease were treated between 1975 and 1988. Ten patients underwent staging laparotomy by which we had to change the pathological stage in 3 patients because occult splenic lesions were detected histologically. Patients with early disease were treated mainly with radiotherapy (RT) and those with advanced disease received modified MOPP chemotherapy with or without RT. Twenty-six patients entered complete remission, and relapse occurred in 7 including 5 patients with stage III disease. Four patients died of the disease and 4 of other causes. The actuarial survival at 5 and 10 years were 80.1% and 47.1% respectively. The actuarial relapse free rate at 10 years was 65.8%. Fourteen patients are in good health after completion of treatment, and 9 healthy babies were born to 5 patients including 3 female patients. The goal of therapy in Hodgkin's disease is cure. Treatment strategy must be based on proper staging and consideration of iatrogenic morbidity such as sterility and second malignancy.
1975年至1988年间,金泽大学对28例霍奇金病患者进行了治疗。10例患者接受了分期剖腹术,其中3例因组织学检查发现隐匿性脾脏病变而改变了病理分期。早期疾病患者主要接受放射治疗(RT),晚期疾病患者接受改良MOPP化疗,联合或不联合RT。26例患者进入完全缓解期,7例复发,其中5例为III期疾病患者。4例患者死于该病,4例死于其他原因。5年和10年的精算生存率分别为80.1%和47.1%。10年的精算无复发生存率为65.8%。14例患者在完成治疗后身体健康,5例患者(包括3例女性患者)生育了9名健康婴儿。霍奇金病的治疗目标是治愈。治疗策略必须基于正确的分期,并考虑到如不育和第二原发恶性肿瘤等医源性发病率。